Ray Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Ray heeft een totaal eigen vermogen van ₩110.9B en een totale schuld van ₩93.3B, wat de schuld-eigenvermogensverhouding op 84.1% brengt. De totale activa en totale passiva bedragen respectievelijk ₩244.1B en ₩133.2B.

Belangrijke informatie

84.1%

Verhouding schuld/eigen vermogen

₩93.29b

Schuld

Rente dekkingsratio	n/a
Contant	₩22.59b
Aandelen	₩110.95b
Totaal verplichtingen	₩133.17b
Totaal activa	₩244.12b

Recente financiële gezondheidsupdates

Recent updates

Ray Co., Ltd. (KOSDAQ:228670) Not Doing Enough For Some Investors As Its Shares Slump 32%

Aug 05

Ray (KOSDAQ:228670) Has A Somewhat Strained Balance Sheet

Jul 24

Market Still Lacking Some Conviction On Ray Co., Ltd. (KOSDAQ:228670)

May 25

The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence

Mar 14

Is Ray (KOSDAQ:228670) Using Too Much Debt?

Mar 16

What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

Feb 21

With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

Feb 02

We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

Jan 14

If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

Dec 27

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Dec 08

Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Nov 19

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₩134.2B ) A228670 } overtreffen de korte termijn passiva ( ₩92.1B ).

Langlopende schulden: De kortetermijnactiva A228670 ( ₩134.2B ) overtreffen de langetermijnschulden ( ₩41.1B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 63.7% ) A228670 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van A228670 is de afgelopen 5 jaar gestegen van 8.8% naar 84.1%.

Schuldendekking: De operationele kasstroom van A228670 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van A228670 op haar schulden goed worden gedekt door EBIT.

Ray Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Ray (KOSDAQ:228670) Has A Somewhat Strained Balance Sheet

Is Ray (KOSDAQ:228670) Using Too Much Debt?

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Recent updates

Ray Co., Ltd. (KOSDAQ:228670) Not Doing Enough For Some Investors As Its Shares Slump 32%

New minor risk - Share price stability

Ray (KOSDAQ:228670) Has A Somewhat Strained Balance Sheet

New minor risk - Shareholder dilution

Market Still Lacking Some Conviction On Ray Co., Ltd. (KOSDAQ:228670)

New major risk - Financial position

Price target decreased by 7.8% to ₩30,800

New minor risk - Shareholder dilution

Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.

Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.

Full year 2023 earnings released: ₩140 loss per share (vs ₩541 profit in FY 2022)

The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: ₩231 (vs ₩172 in 3Q 2022)

Now 22% undervalued after recent price drop

Price target decreased by 7.9% to ₩43,000

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 32%

Consensus EPS estimates fall by 37%

Investor sentiment improves as stock rises 18%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Price target decreased to ₩29,900

Price target decreased to ₩38,767

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to ₩38,767

Third quarter 2021 earnings released: EPS ₩381 (vs ₩181 in 3Q 2020)

Ray Co., Ltd. announced that it has received KRW 31.5 billion in funding

Ray Co., Ltd. announced that it expects to receive KRW 31.5 billion in funding

Full year 2020 earnings released: EPS ₩1,188 (vs ₩1,915 in FY 2019)

Is Ray (KOSDAQ:228670) Using Too Much Debt?

Ray Co., Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?

Investor sentiment improved over the past week

New 90-day high: ₩62,500

With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?

We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide

New 90-day high: ₩56,300

If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns

New 90-day high: ₩47,300

Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly

Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?

Market bids up stock over the past week

New 90-day low: ₩40,200

New 90-day low - ₩41,100

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven